St. John's Wort Oil

Hypericum perforatum

Evidence Rating

C Moderate

Confidence Level

Moderate

Traditions

Western

Last Updated

2/9/2026

Summary

St. John's Wort oil (Oleum Hyperici, "Red Oil") is a traditional European wound-healing preparation that is well-recognized in the German-speaking world but virtually unknown in Anglophone dermatology. The topical use is approved by Commission E and ESCOP for minor wounds, burns, and skin inflammation. Hyperforin is the primary wound-healing active compound, stimulating keratinocyte differentiation. Clinical evidence is limited but supportive, including a positive RCT for cesarean wound healing. Photosensitivity concerns, while valid for oral/systemic use, appear minimal for topical application at standard concentrations.

⚠️

Drug Interactions

This herb has significant drug interactions. Do not use if you are taking medications without consulting a healthcare provider first. See detailed interaction information below.

Regulatory Status

Regulatory BodyStatus
Commission E (Germany)✓ Approved
ESCOP (European)✓ Approved
EMA/HMPC (EU)✓ Approved

Metadata

FieldValue
Common Names (English)St. John’s Wort Oil, Red Oil, Hypericum Oil
Common Names (German)Johanniskrautol, Rotol, Hypericum-Ol
Botanical NameHypericum perforatum L.
Plant FamilyHypericaceae (formerly Clusiaceae/Guttiferae)
Parts UsedFlowering tops macerated in oil (Oleum Hyperici); also tincture and ointment
Evidence Quality RatingModerate — Commission E and ESCOP approval for topical use; limited clinical trials but strong traditional use basis

Approved Indications

Commission E (Germany)

  • Approved for both internal and external use
  • External indications: Treatment and post-treatment of sharp and blunt injuries; myalgia; first-degree burns
  • The oil preparation (Oleum Hyperici) is specifically included in the monograph

ESCOP (European Scientific Cooperative on Phytotherapy)

  • Approved for external use
  • Indications: Mild skin inflammations (e.g., sunburn); small wounds; minor burns

EMA/HMPC (European Medicines Agency)

  • Traditional Use classification for topical preparations
  • Indications: Traditional herbal medicinal product for symptomatic treatment of minor inflammations of the skin and as an aid in healing of minor wounds
  • Note: The EMA monograph primarily addresses oral use for depression; topical use receives less detailed assessment

Agreement/Disagreement Between Bodies

  • Good agreement on minor wounds and burns (first-degree)
  • Commission E is broadest, including myalgia and sharp/blunt injuries
  • ESCOP includes sunburn specifically
  • EMA provides minimal detail on topical use compared to oral use
  • Important: All bodies recognize the topical use as distinct from oral antidepressant use

Conditions Treated

Primary (Monograph-Supported)

  • First-degree burns (including sunburn / dermatitis solaris)
  • Minor wounds (sharp and blunt injuries)
  • Mild skin inflammations
  • Myalgia (Commission E)

Secondary (Clinical/Traditional Use)

  • Pressure sores (case reports)
  • Cesarean wound healing (RCT evidence)
  • Atopic dermatitis (hyperforin-rich preparations)
  • Abrasions and contusions
  • Bruises
  • Ulcers (traditional)
  • Neonatal skin care (traditional use in some Mediterranean cultures)

Mechanism of Action

Key Active Compounds

  • Hyperforin (phloroglucinol derivative) — primary wound-healing compound; stimulates keratinocyte growth and differentiation; potent antimicrobial
  • Hypericin (naphthodianthrone) — photosensitizer; anti-inflammatory; antimicrobial; gives the oil its characteristic red color
  • Pseudohypericin — related naphthodianthrone
  • Flavonoids (hyperoside, rutin, quercetin) — antioxidant, anti-inflammatory
  • Tannins — astringent
  • Essential oil — antimicrobial

Mechanisms

  1. Keratinocyte stimulation: Hyperforin stimulates growth and differentiation of keratinocytes, directly promoting re-epithelialization [Source: PMID 10809859]
  2. Anti-inflammatory: Hyperforin inhibits COX-1, 5-LOX, and allostimulatory capacity of epidermal cells; reduces inflammatory cytokine release
  3. Antimicrobial: Hyperforin has potent activity against Gram-positive bacteria including MRSA; hypericin has antiviral properties
  4. Antioxidant: Flavonoid-mediated free radical scavenging
  5. Immunomodulatory: Topical hyperforin inhibits the allostimulatory capacity of epidermal cells (relevant to atopic dermatitis) [Source: PMID 10809859]

Preparation of Oleum Hyperici

The traditional preparation involves macerating fresh flowering tops in olive or sunflower oil and exposing the mixture to sunlight for 2-6 weeks. During this period, the oil turns blood-red (from hypericin extraction) and the preparation is then filtered and ready for use. This maceration method is critical to the pharmacological profile — it extracts lipophilic compounds differently than hydroalcoholic tinctures.


Clinical Evidence Summary

Key Clinical Trials

StudyDesignNConditionResult
Samadi et al. (2010)RCT, double-blind144Cesarean wound healingHypericum cream significantly improved wound healing, reduced scar formation, pain, and pruritus (p < 0.05)
Schempp et al. (2003)RCT, half-side comparison21Atopic dermatitisHyperforin-rich cream (1.5% hyperforin) significantly superior to vehicle for eczema severity (p < 0.05)
Schempp et al. (2000)Controlled study12Photosensitivity assessmentNo clinically significant phototoxicity from topical application

Case Reports

  • Yildirim et al. (2016): Pressure sore treatment with H. perforatum oily extract — positive wound healing outcomes in case report [Source: J Ethnopharmacol]

Evidence Assessment

  • Cesarean wound healing: One well-designed RCT showing significant benefit
  • Atopic dermatitis: One positive small RCT using hyperforin-rich preparation
  • Burns/sunburn: Primarily traditional use evidence; no high-quality RCTs identified [NEEDS-RESEARCH]
  • General wound healing: Strong pharmacological rationale but limited clinical trials
  • Overall: Clinical research is still scarce despite strong traditional use and pharmacological evidence. More RCTs are needed, particularly for the burns indication that is the primary traditional use. [NEEDS-RESEARCH]

European vs US/Anglophone Consensus

AspectEuropean PositionUS/Anglophone Position
Regulatory statusCommission E and ESCOP approved for topical useNot recognized; no FDA monograph for topical use
Clinical awarenessWidely known topical wound/burn remedy, especially in German-speaking countriesVirtually unknown — St. John’s Wort is associated exclusively with oral antidepressant use
Product availabilityOleum Hyperici widely available in pharmaciesRarely available; not stocked in typical pharmacies
Clinical usePart of standard phytotherapy wound care toolkitNot used in conventional dermatology
Research focusBalanced attention to both oral and topical usesOverwhelming focus on oral antidepressant use; topical research neglected

This is perhaps the single largest gap in US/Anglophone awareness among all herbs in this knowledge base. The topical wound-healing use of St. John’s Wort oil is a well-established component of European folk and professional medicine that has essentially zero penetration into English-speaking dermatological practice.


Safety Profile

Contraindications

  • Known hypersensitivity to Hypericum perforatum
  • Not recommended on heavily irradiated skin or immediately before intense sun exposure (precautionary)

Drug Interactions (Topical Use)

  • Topical: No significant drug interactions reported (the extensive drug interaction profile of oral St. John’s Wort does NOT apply to topical use)
  • The CYP3A4 induction and serotonin syndrome risks are specific to oral/systemic administration

Side Effects

  • Photosensitivity: The most commonly raised concern. However, clinical evidence (Schempp et al. 2000) shows no severe phototoxic potential from topical application at standard concentrations. A trend toward increased sensitivity was detected with sensitive photometric measurement, potentially relevant in fair-skinned individuals, diseased skin, or with extended sun exposure [Source: PMID 10885442]
  • Rare: Contact dermatitis (uncommon)
  • Generally well tolerated topically

Pregnancy/Lactation

  • Topical use: No specific contraindication established; generally considered safe
  • Oral use: Controversial during pregnancy/lactation (but this is not relevant to topical wound care)

Clinical Dosage

Topical Preparations

FormDosage/ConcentrationNotes
Oleum Hyperici (macerated oil)Hypericin ~110 microg/mLTraditional preparation; apply directly or as dressing
OintmentHypericin ~30 microg/mLFor skin inflammation
Hyperforin-rich cream1.5% hyperforinUsed in atopic dermatitis trial
Tincture (topical)1:10 in olive oil (traditional)For wound cleansing

Key Commercial Products (Europe)

  • Oleum Hyperici (various pharmacy preparations)
  • Hypericum oil (red oil) — widely available in German/Austrian pharmacies
  • Behnke Johanniskrautol
  • Various anthroposophic preparations (Wala, Weleda)

Sources

  • Commission E Monograph: Hypericum perforatum (includes external use)
  • ESCOP Monograph: Hyperici herba
  • EMA Assessment: Hypericum perforatum (primarily oral; topical use noted)
  • Altmeyers Encyclopedia: Hyperici herba
  • Samadi et al. (2010). Hypericum for cesarean wound healing. PMID: 20064022
  • Schempp et al. (2003). Hyperforin-rich cream for atopic dermatitis. Phytomedicine.
  • Schempp et al. (2000). Topical photosensitivity. PMID: 10885442
  • Planta Medica (2013). Topical application of St. John’s wort review. PMID: 24214835

Connections

  • Distinct from oral antidepressant use — do not conflate safety profiles
  • Compare with Calendula and Comfrey for wound-healing evidence
  • The photosensitivity concern parallels oxidation concerns with Tea Tree (product quality matters)
esc
↑↓ navigate open esc close